The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel modes of action are urgently needed.

Antibiotic resistance is a growing problem, and it’s one that large pharmaceutical companies have largely abandoned. Some startups are filling the gap, and a new one, ArrePath, has novel molecules ...

New drug that disrupts two cellular targets would make it much harder for bacteria to evolve resistance. A new antibiotic that works by disrupting two different cellular targets would make it 100 ...